Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China flag China · Delayed Price · Currency is CNY
63.45
+0.38 (0.60%)
At close: Nov 17, 2026

Shanghai OPM Biosciences Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
41.1441.721.0554.04105.3760.39
Depreciation & Amortization
50.0250.0246.0236.8333.8528.19
Other Amortization
14.7514.7512.055.885.174.07
Loss (Gain) From Sale of Assets
---0.09--0.29-
Asset Writedown & Restructuring Costs
9.589.587.510.0200.02
Loss (Gain) From Sale of Investments
-21.81-21.81-18.25-14.59-5.81-4.18
Provision & Write-off of Bad Debts
2.662.666.926.424.760.31
Other Operating Activities
103.9410.67-0.61.993.015.11
Change in Accounts Receivable
12.212.2-39.23-24.83-46.04-6.3
Change in Inventory
-18.53-18.53-9.41-5.62-10.56-21.26
Change in Accounts Payable
4.844.8438.54-8.1616.8240.52
Change in Other Net Operating Assets
4.64.65.56.875.797.87
Operating Cash Flow
196.09103.3969.2557.95111.62114.63
Operating Cash Flow Growth
77.05%49.30%19.49%-48.08%-2.62%3478.75%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-26.87-56.07-120.86-77.55-146.96-105.98
Sale of Property, Plant & Equipment
1.16---6.78-
Cash Acquisitions
-561.24-20-0.02--
Divestitures
-0.01-0.01----
Investment in Securities
-129.41-89.71-253.73-73.26-283.28-38
Other Investing Activities
7.048.134.051.2537.873.99
Investing Cash Flow
-709.34-157.64-370.54-149.53-385.59-139.99

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-0.12--32.3442.82
Long-Term Debt Repaid
--12.59-11.3-45.42-62.79-21.6
Lease Payments
-12.47-12.47-11.3-10.26-5.74-4.75
Net Debt Issued (Repaid)
-2.51-12.47-11.3-45.42-30.4521.22
Issuance of Common Stock
362.246.55--1,523-
Repurchase of Common Stock
---37.25-13.75--
Common Dividends Paid
-28.42-48.83-51.22-73.83-2.08-1.8
Other Financing Activities
-29.3-2.310.13--15.740.2
Financing Cash Flow
302.01-57.06-99.64-133.011,47419.62

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-12.91-5.352.420.952.35-0.24
Net Cash Flow
-224.14-116.66-398.51-223.641,203-5.99

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
169.2247.32-51.61-19.59-35.348.64
Free Cash Flow Growth
698.00%-----
Free Cash Flow Margin
20.58%13.33%-17.36%-8.06%-12.01%4.06%
Free Cash Flow Per Share
1.270.42-0.44-0.17-0.350.10
Levered Free Cash Flow
1.44-22.97-48.83-38.18-100.94-34.34
Unlevered Free Cash Flow
5.12-21.29-46.88-36.16-97.83-31.35
Free Cash Flow After Leases
156.7534.85-62.91-29.85-41.083.89

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
64.1951.7229.911.3828.4713.42
Change in Working Capital
-4.18-4.18-5.37-32.64-34.4420.7